SEC Filing Summary: BioSig Technologies, Inc. (BSGM)
Business Context and Reporting Period
This Form 8-K was filed by BioSig Technologies, Inc. (not Streamex Corp.) on October 29, 2024, reporting an event that occurred on October 24, 2024. The company is incorporated in Delaware and its common stock trades on The NASDAQ Capital Market under the symbol BSGM.
Key Financial Metrics
The filing text does not provide specific values for revenue, profit, cash flow, margins, debt, or liquidity. The only financial metric disclosed is the stock's closing bid price, which failed to meet the $1.00 per share minimum requirement over the period from June 11, 2024, through October 23, 2024.
Material Changes
The primary material change is the receipt of a deficiency notice from Nasdaq Listing Qualifications. The company no longer meets the minimum bid price requirement of $1.00 per share. Consequently, the company has been granted an initial compliance period of 180 calendar days to regain compliance.
Outlook, Risks, and Management Commentary
- Compliance Path: To regain compliance within the 180-day period, the closing bid price must be at least $1.00 for a minimum of ten consecutive business days.
- Contingency Plan: If the company fails to regain compliance during the initial period, it may be eligible for a second compliance period. This would require meeting the market value of publicly held shares and all other initial listing standards, potentially necessitating a reverse stock split.
- Risk: Failure to meet these requirements could result in delisting from The NASDAQ Capital Market.
Key Facts for Investor Verification
- Verify the current trading price of BSGM to assess the likelihood of meeting the $1.00 threshold for ten consecutive days.
- Monitor the company's announcements regarding a potential reverse stock split if the initial 180-day compliance period expires without success.
- Confirm the company's market value of publicly held shares to ensure eligibility for a second compliance period if needed.
- Note the discrepancy between the requested company name (Streamex Corp.) and the actual registrant (BioSig Technologies, Inc.).